Want to see GB:OPT full AI Analyst Report?
Top Page
Optima Health PLC
(LSE:OPT)
Select Model
Select Model
Rating:53Neutral
Price Target:
181.00 p
▼(-4.23% Downside)
Action:N/A
Date:01/04/26
The score is held back primarily by weakened cash generation (negative free cash flow in 2025) and a high valuation (P/E ~50) despite only thin margins. Financial performance shows improvement with a return to profitability and modest leverage, but volatility reduces confidence. Technical signals are mixed with neutral momentum and the price below longer-term averages.
Positive Factors
Revenue Growth
Sharp revenue expansion to roughly £105m in 2025 shows the company can scale its occupational health services and win contracts. Sustained top-line growth improves unit economics potential and provides a larger base to absorb costs and invest in service capability over the medium term.
Negative Factors
Weak Cash Generation
Free cash flow swung negative in 2025 despite reported profits, signaling cash conversion issues or elevated working-capital/investment needs. Persistent or recurring negative FCF would constrain reinvestment, raise funding requirements, and increase execution risk over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sharp revenue expansion to roughly £105m in 2025 shows the company can scale its occupational health services and win contracts. Sustained top-line growth improves unit economics potential and provides a larger base to absorb costs and invest in service capability over the medium term.
Read all positive factors
Optima Health PLC (OPT) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£208.30M
Dividend YieldN/A
Average Volume (3M)135.53K
Price to Earnings (P/E)48.1
Beta (1Y)-0.28
Revenue Growth8.46%
EPS GrowthN/A
CountryUK
Employees1,511
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.04
Shares Outstanding108,775,375
10 Day Avg. Volume155,484
30 Day Avg. Volume135,525
Financial Highlights & Ratios
PEG Ratio-0.14
Price to Book (P/B)0.52
Price to Sales (P/S)0.84
P/FCF Ratio-82.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.14
Revenue Forecast (FY)£207.06M
Optima Health PLC Business Overview & Revenue Model
Company Description
Optima Health Plc specializes in delivering workplace health and employee wellbeing solutions. Their extensive range of offerings includes initiatives for engagement and overall wellness, alongside dedicated services for mental health and musculos...
How the Company Makes Money
Optima Health PLC makes money primarily by selling occupational health and wellbeing services to organizations (typically employers) under contracted arrangements. Revenue is generated through fees for delivering services such as occupational heal...
Optima Health PLC Financial Statement Overview
Summary
Income Statement
63
Positive
Balance Sheet
68
Positive
Cash Flow
45
Neutral
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 113.75M | 105.05M | 110.89M | 115.35M | 22.39M |
| Gross Profit | 24.41M | 33.04M | 36.47M | 36.94M | 8.04M |
| EBITDA | 16.42M | 13.65M | 10.06M | 11.06M | 1.74M |
| Net Income | 3.53M | 1.65M | -1.08M | 1.59M | -246.00K |
Balance Sheet | |||||
| Total Assets | 221.43M | 218.14M | 210.39M | 225.27M | 192.56M |
| Cash, Cash Equivalents and Short-Term Investments | 8.27M | 14.80M | 8.22M | 12.73M | 6.90M |
| Total Debt | 19.40M | 21.68M | 12.45M | 57.87M | 34.06M |
| Total Liabilities | 51.97M | 50.02M | 48.11M | 97.24M | 66.25M |
| Stockholders Equity | 169.45M | 168.12M | 127.62M | 128.03M | 126.31M |
Cash Flow | |||||
| Free Cash Flow | 7.93M | -1.06M | 10.00M | 2.40M | -1.63M |
| Operating Cash Flow | 9.76M | 2.69M | 12.85M | 6.59M | -836.00K |
| Investing Cash Flow | -11.76M | -5.65M | -2.85M | 843.00K | 7.77M |
| Financing Cash Flow | 880.00K | -3.33M | -1.63M | -1.61M | -205.00K |
Optima Health PLC Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | £4.12B | 32.41 | 10.53% | 2.11% | 3.29% | -10.58% | |
63 Neutral | £471.57M | 28.60 | 6.65% | 1.66% | 3.46% | 46.25% | |
62 Neutral | £873.15M | 52.57 | 2.22% | 1.37% | 4.54% | -34.92% | |
60 Neutral | £819.00M | 53.50 | 5.35% | 0.67% | 4.41% | -8.04% | |
58 Neutral | £607.01M | 60.61 | 3.87% | 1.25% | 28.96% | 39.58% | |
53 Neutral | £208.30M | 48.12 | 2.09% | ― | 8.46% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
GB:OPT
Optima Health PLC
191.50
-14.44
-7.01%
GB:AMS
Advanced Medical Solutions
280.00
65.81
30.73%
GB:CTEC
ConvaTec
213.80
-68.23
-24.19%
GB:CRW
Craneware
1,360.00
-719.63
-34.60%
GB:CVSG
CVS Group plc
1,177.00
-64.36
-5.18%
GB:SPI
Spire Healthcare
215.00
-7.48
-3.36%
Optima Health PLC Corporate Events
Business Operations and StrategyFinancial DisclosuresM&A TransactionsPrivate Placements and Financing
Optima Health Launches £35m Underwritten Open Offer to Fund PAM Deal and Boost Growth
Positive
Mar 31, 2026
Optima Health plc has launched an underwritten open offer to raise approximately £35m through the issue of up to 19,999,149 new shares at 175 pence, mainly to repay a £30m bridge facility used to fund its recent acquisition of PAM Health...
Business Operations and StrategyM&A TransactionsPrivate Placements and Financing
Optima Health clears Irish FDI hurdle for £100m PAM acquisition
Positive
Mar 24, 2026
Optima Health has secured Irish foreign direct investment clearance for its approximately £100 million cash acquisition of PAM Healthcare Limited, a major occupational health and wellness provider in the UK and Ireland, making the deal uncond...
Business Operations and StrategyExecutive/Board ChangesM&A Transactions
Optima Health Plans CFO Transition Ahead of PAM Healthcare Acquisition
Positive
Mar 23, 2026
Optima Health plc, the UK’s leading provider of technology-enabled corporate health and wellbeing solutions, has built its business over 25 years on tailored occupational health services and innovative systems for employers. The company focu...
Business Operations and StrategyFinancial Disclosures
Optima Health Strikes Perkbox Partnership to Expand Wellbeing Reach
Positive
Mar 12, 2026
Optima Health has entered a strategic partnership with global employee benefits platform Perkbox to deliver a full suite of employee assistance and mental health services to Perkbox’s client base. Under the five-year agreement, Optima will t...
Business Operations and Strategy
Optima Health Chair Julia Robertson Buys Shares, Signalling Confidence in Growth
Positive
Feb 24, 2026
Optima Health plc has disclosed that its chairman, Julia Robertson, has purchased 21,500 ordinary shares in the company at a price of 185 pence per share. The transaction, completed on 23 February 2026 on the London Stock Exchange’s AIM mark...
Business Operations and StrategyM&A TransactionsPrivate Placements and Financing
Optima Health to Buy PAM Healthcare in £100m Deal, Cementing UK Occupational Health Lead
Positive
Feb 16, 2026
Optima Health has agreed to acquire PAM Healthcare Limited, a leading occupational health and wellbeing provider in the UK and Ireland, for about £100 million in cash, subject only to Irish foreign investment clearance. The deal will be funde...
Business Operations and Strategy
Optima Health Appoints Cavendish as Joint Broker to Support Growth
Positive
Feb 16, 2026
Optima Health plc, a UK-based specialist in technology-enabled occupational health and wellbeing services, supports millions of employees via a nationwide network of clinics and an extensive clinical workforce. The company also extends its occupat...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.